Evidence map›Paper›PMID 32249386›Full record

ArticleNeurochemical research2021

Calpain-Inhibitors Protect Frataxin-Deficient Dorsal Root Ganglia Neurons from Loss of Mitochondrial Na

Elena Britti, Fabien Delaspre, Jordi Tamarit, Joaquim Ros

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. The Molecular Mechanism of Yellow Mushroom (Frontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Elena BrittiDepartament de Ciències Mèdiques Bàsiques, Universitat de Lleida, IRBLleida, Lleida, Spain.
Fabien DelaspreDepartament de Ciències Mèdiques Bàsiques, Universitat de Lleida, IRBLleida, Lleida, Spain.
Jordi TamaritDepartament de Ciències Mèdiques Bàsiques, Universitat de Lleida, IRBLleida, Lleida, Spain.
Joaquim RosDepartament de Ciències Mèdiques Bàsiques, Universitat de Lleida, IRBLleida, Lleida, Spain. joaquim.ros@cmb.udl.cat.
Biomedical Research Institute of Lleida · ESUniversitat de Lleida · ES

Funding

Ministerio de Economía, Industria y Competitividad, Gobierno de España SAF2017-83883-R
6 · The paper itself

Abstract

Calpains are calcium-dependent proteases activated in apoptotic cell death and neurodegeneration. Friedreich Ataxia is a neurodegenerative rare disease caused by frataxin deficiency, a mitochondrial protein. Dorsal root ganglion (DRG) sensory neurons are among the cellular types most affected in this disease. We have previously demonstrated that frataxin-deficient DRGs show calpain activation, alteration in calcium levels and decreased content of the Na

Indexed as

AnimalsApoptosisCalciumCalpainCarrier ProteinsCysteine Proteinase InhibitorsDipeptidesFrataxinGanglia, SpinalIron-Binding ProteinsMicrofilament ProteinsMitochondriaMitochondrial Membrane Transport ProteinsNeuronsProteolysisRatsCalciumCalpaincalpain inhibitor IIIcalpeptinCarrier ProteinsCysteine Proteinase InhibitorsDipeptidesFrataxinIron-Binding ProteinsMicrofilament ProteinsMitochondrial Membrane Transport ProteinsSlc8b1 protein, ratSodium-Calcium ExchangerSpectrinCalpainsCalpeptinFriedreich AtaxiaMDL28170NCLX

Identifiers

PMID32249386
OpenAlexW3014811762

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.